|
Montreal Heart Attack Readjustment Trial (M-HART) Clinical Trials Information presented on Clinical Trials Search isn't intended to be a substitute for proven healthcare advice, trips or treatment using a real physician. We are not docs. Always confer with your mD on Montreal Heart Attack Readjustment Trial (M-HART) conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Montreal Heart Attack Readjustment Trial (M-HART) Clinical research trials and Montreal Heart Attack Readjustment Trial (M-HART) medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectiveness of new drugs. The intention of the studies / projects is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector corporations to detect remedies for all forms of circumstances, like Montreal Heart Attack Readjustment Trial (M-HART). Montreal Heart Attack Readjustment Trial (M-HART) Clinical Trials and other clinical trials allow for volunteers to undergo healthcare treatment options before they are available to the masses. Most times the participants receive treatment for free, and every now and again they are paid for their time. Occasionally there is a cost for a Montreal Heart Attack Readjustment Trial (M-HART) clinical trial. Subjects typically recieve the finest healthcare available for their Montreal Heart Attack Readjustment Trial (M-HART) condition. Hazards are a reality, nonetheless, and might include more or frequent mD trips, health risks (potentially life-endangering), and/or the treatment being ineffective. Trials are federally regulated with stern guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "M" Clinical Trials Conditions > Montreal Heart Attack Readjustment Trial (M-HART)  Montreal Heart Attack Readjustment Trial (M-HART)
Montreal Heart Attack Readjustment Trial (M-HART)
For Condition: Cardiovascular Diseases,Coronary Disease,Heart Diseases,Myocardial Infarction,Myocardial Ischemia
Status: Completed
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: To examine the impact of a monitoring and social support intervention upon survival of myocardial infarction patients.
Details: BACKGROUND: Despite evidence that social support and various aspects of negative affect may influence prognosis after a myocardial infarction, the impact of psychosocial supportive interventions had not been demonstrated. Further, little was known about the impact of psychosocial and/or interventions among women patients. Previous work by Nancy Frasure-Smith and colleagues suggested that a one-year post-myocardial infarction program of monthly telephone monitoring of psychological stress symptoms, coupled with home nursing visits for patients reporting high stress levels, had an impact on one-year cardiac mortality and long-term myocardial infarction recurrences among men. However, methodological difficulties prevented drawing firm conclusions. A trial which corrected for these difficulties was conducted involving 948 post-myocardial infarction patients. However, the project was too small to study enough patients to assess program impact separately for men and women. The trial was supported by Canadian sources. The NHLBI supplemented the study in order to expand the sample size from 948 patients to 1,376 ptients to allow gender analysis. DESIGN NARRATIVE: Randomized, with a multi-hospital design. At the time of discharge from the hospital following a documented myocardial infarction, patients were randomized to treatment and control groups. The control group received usual care from their physicians. In addition to usual care, treatment patients were phoned monthly and responded to a standardized index of psychological symptoms of stress. Those with high stress levels received home nursing visits to reduce their stress. Patients in both groups took part in three interviews: in the hospital, at three months, and at one year post-discharge. Interviews assessed depression, anxiety, anger, self-perceived stress, social support, medication compliance, and cardiac risk factors. Salivary cortisol, a physiological indicator of stress, was assessed on the evening following each interview. Indicators of residual myocardial infarction, ischemia, and arrhythmias were obtained from hospital charts. Outcome data were obtained from hospital charts, death certificates, and Quebec Medicare data and were blindly classified by study cardiologists.
Eligibility:
Study Type: Interventional, Educational/Counseling/Training, Placebo Control
Minimum Age/Maximum Age: 18 Years/75 Years
Genders: Both
Protocol Entry Criteria: Men and women myocardial infarction patients.
Total Enrollment:
Location and Contact Information:
Additional Information:
Study ID Numbers: 76;
Study Start Date: February 1992
Record last reviewed: December 1996
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00000533
Other Heart Diseases Studies:
1. Nurses' Health Study
2. Stroke and MI in Users of Estrogen/Progestogen
3. Modifying Oxidative Damage in WAVE - Ancillary to WAVE
4. Coronary Screening in a High Risk Subset
5. Insulin Resistance Atherosclerosis Study (IRAS)
Related Studies:
Other Heart Diseases Clinical Trials
Other Clinical Trials
Other Clinical Trials
Montreal Heart Attack Readjustment Trial (M-HART)
|
|
|
|
|
|
|
|
